Galecto Inc
NASDAQ:GLTO
Galecto Inc
Total Liabilities
Galecto Inc
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Galecto Inc
NASDAQ:GLTO
|
Total Liabilities
$5.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Total Liabilities
kr4.2B
|
CAGR 3-Years
26%
|
CAGR 5-Years
47%
|
CAGR 10-Years
15%
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Total Liabilities
kr387.2m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
28%
|
CAGR 10-Years
29%
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Total Liabilities
€1B
|
CAGR 3-Years
86%
|
CAGR 5-Years
87%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Total Liabilities
kr3.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
39%
|
CAGR 10-Years
26%
|
Bioporto A/S
CSE:BIOPOR
|
Total Liabilities
kr29.7m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
See Also
What is Galecto Inc's Total Liabilities?
Total Liabilities
5.9m
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's Total Liabilities amounts to 5.9m USD.
What is Galecto Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
6%
Over the last year, the Total Liabilities growth was -48%. The average annual Total Liabilities growth rates for Galecto Inc have been -1% over the past three years , 6% over the past five years .